The Impact of Magnesium on Exercise Tolerance, Quality of Life and Clinical Outcomes in Chronic Heart Failure Patients

PHASE3RecruitingINTERVENTIONAL

Enrollment

320

Participants

Timeline

Start Date

August 25, 2019

Primary Completion Date

January 1, 2026

Study Completion Date

March 1, 2026

Conditions

Magnesium DeficiencyHeart Failure

Interventions

DRUG

Placebo Oral Tablet

Placebo tablets

DRUG

Magnesium Oxide

Magnesium tablets

Trial Locations (1)

RECRUITING

Leviev Heart Center, Chaim Sheba Medical Center, Ramat Gan

All Listed Sponsors

collaborator

Naveh Pharma (1996) Ltd.

UNKNOWN

lead

Sheba Medical Center

OTHER_GOV